Safe administration of chemotherapy in mast cell activation syndrome

INTRODUCTION: Mast Cell Activation Syndrome (MCAS) is an immunogenic disorder typically presenting with episodic multi-organ symptoms, caused by the inappropriate and aberrant release of mast cell mediators. Symptoms may be severe, including anaphylaxis and often occur in response to specific trigge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lythgoe, MP, Krell, J, McNeish, IA, Tookman, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193587/
https://www.ncbi.nlm.nih.gov/pubmed/33032491
http://dx.doi.org/10.1177/1078155220953879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193587/
https://www.ncbi.nlm.nih.gov/pubmed/33032491
http://dx.doi.org/10.1177/1078155220953879

Ejemplares similares